MIRUM PHARMACEUTICALS INC MIRM
COM · Common Stock · CUSIP 604749101 · ISIN US6047491013
Biopharmaceutical company
- SectorHealth care
- IndustryPharmaceutical Preparations
- HeadquartersFoster City, CA
- Founded2018
- Websitemirumpharma.com
- FilingsSEC EDGAR
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Shares outstanding: 23.0m as of 2019-11-01, from the company's own SEC filing; the percentage can still exceed 100%: lent-out shares are counted by the lender and the buyer, and some reports overlap without saying so. Implied quarter-end price ≈ $24.52.
Major shareholders (over 5%)
Anyone who owns more than 5% of a class of the company's shares has to say so: on Schedule 13D if they may try to influence or control the company, on 13G if they're a passive investor, and update it as the stake changes. Each holder's latest filing, from 19 Dec 2024 on; percentages are of the share class, as the holder worked them out.
| Holder | Stake |
|---|---|
| Janus Henderson Group Ltd. 13G · institution -2.1 pts · filed 2026-08-13 | 9.7% |
Frazier Life Sciences IX, L.P.
13D · may seek influence
-0.8 pts · filed 2026-01-27
Stated purposeItem 4 is hereby amended and restated in its entirety to read as follows: Each of FLS IX, FLS X, FLSPF, FLS XI and FLS XII acquired the FLS IX Shares, the FLS X Shares, the FLSPF Shares, the FLS XI Shares and the FLS XII Shares, as the case may be, for investment purposes. Depending on market conditions, its continuing evaluation of the business and prospects of the Issuer and other factors, FLS IX, FLS X, FLSPF, FLS XI and FLS XII and the other Reporting Persons may dispose of or acquire additional shares of the Issuer. Except as set forth above, none of the Reporting Persons has any present plans which relate to or would result in: (a) The acquisition by any person of additional securities of the Issuer, or the disposition of securities of the Issuer; (b) An extraordinary corporat… Full filing |
6.8% |
| FMR LLC 13G · institution new · filed 2026-08-06 | 6.2% |
| BlackRock, Inc. 13G · institution filed 2026-04-27 | 5.7% |
Fell to 5% or below in the last year: VANGUARD GROUP INC (0.0%, 2026-03-27), EVENTIDE ASSET MANAGEMENT, LLC (4.1%, 2026-02-13)
Insider purchases and sales in Q4 2019
Shares bought or sold by the company's own officers, directors and 10% owners, in the open market or privately, as they reported to the SEC on Form 4 (due within two business days of the trade). Grants, option exercises, shares withheld for tax and gifts aren't included.
None reported in Q4 2019.
Holders, Q4 2019
| Manager | Shares | Change |
|---|---|---|
| NEA Management Company, LLC 4.86% of their portfolio | 4.2m $102.7m | — |
| FRAZIER MANAGEMENT LLC 14.67% of their portfolio | 3.6m $87.5m | — |
| DEERFIELD MANAGEMENT COMPANY, L.P. 2.70% of their portfolio | 3.4m $84.6m | — |
| NOVO HOLDINGS A/S 3.86% of their portfolio | 2.4m $60.0m | — |
| Rock Springs Capital Management LP 0.96% of their portfolio | 1.2m $30.5m | — |
| BAKER BROS. ADVISORS LP 0.04% of their portfolio | 333.3k $8.2m | — |
| Boxer Capital, LLC 0.44% of their portfolio | 317.0k $7.8m | — |
| BlackRock Inc. 0.00% of their portfolio | 181.2k $4.4m | — |
| GEODE CAPITAL MANAGEMENT, LLC 0.00% of their portfolio | 117.1k $2.9m | — |
| VANGUARD GROUP INC 0.00% of their portfolio | 80.4k $2.0m | — |
| ORBIMED ADVISORS LLC 0.03% of their portfolio | 71.3k $1.7m | — |
| Global IMC LLC 0.59% of their portfolio | 60.5k $1.5m | — |
| Informed Momentum Co LLC 0.25% of their portfolio | 46.8k $1.1m | — |
| NORTHERN TRUST CORP 0.00% of their portfolio | 46.6k $1.1m | — |
| Worth Venture Partners, LLC 0.33% of their portfolio | 27.1k $666.0k | — |
| Alyeska Investment Group, L.P. 0.01% of their portfolio | 27.1k $664.0k | — |
| STATE STREET CORP 0.00% of their portfolio | 22.8k $560.0k | — |
| MILLENNIUM MANAGEMENT LLC 0.00% of their portfolio | 22.3k $546.0k | — |
| Bank of New York Mellon Corp 0.00% of their portfolio | 11.5k $282.0k | — |
| RAYMOND JAMES & ASSOCIATES 0.00% of their portfolio | 8.8k $217.0k | — |
| MORGAN STANLEY 0.00% of their portfolio | 6.2k $152.0k | — |
| BANK OF AMERICA CORP /DE/ 0.00% of their portfolio | 5.4k $132.0k | — |
| UBS Group AG 0.00% of their portfolio | 4.8k $118.0k | — |
| Ensign Peak Advisors, Inc 0.00% of their portfolio | 4.7k $116.0k | — |
| JPMORGAN CHASE & CO 0.00% of their portfolio | 4.3k $105.0k | — |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM 0.00% of their portfolio | 4.1k $100.0k | — |
| Lindbrook Capital, LLC 0.02% of their portfolio | 2.0k $49.0k | — |
| AMERICAN INTERNATIONAL GROUP, INC. 0.00% of their portfolio | 1.7k $41.0k | — |
| NEW YORK STATE COMMON RETIREMENT FUND 0.00% of their portfolio | 1.6k $40.0k | — |
| Marshall Wace North America L.P. 0.00% of their portfolio | 1.0k $25.0k | — |
| DEUTSCHE BANK AG\ 0.00% of their portfolio | 897 $21.0k | — |
| STRS OHIO 0.00% of their portfolio | 700 $17.0k | — |
| Legal & General Group Plc 0.00% of their portfolio | 551 $14.0k | — |
| CITIGROUP INC 0.00% of their portfolio | 540 $13.0k | — |
| Parallel Advisors, LLC 0.00% of their portfolio | 400 $10.0k | — |
| BANK OF MONTREAL /CAN/ 0.00% of their portfolio | 339 $8.0k | — |
| WELLS FARGO & COMPANY/MN 0.00% of their portfolio | 235 $5.0k | — |
| Ameritas Investment Partners, Inc. 0.00% of their portfolio | 225 $6.0k | — |
| ROYAL BANK OF CANADA 0.00% of their portfolio | 79 $2.0k | — |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0.00% of their portfolio | 0 $0 | — |